Hematologist
CION Cancer Clinics
Myeloid NGS panels: what gets tested and why it matters | CION Cancer Clinics
A myeloid NGS panel reads dozens of genes in blood or marrow cells in one test, looking for changes that drive AML, MDS and MPN. The result helps confirm the diagnosis, sets the risk group and shows whether a targeted medicine may suit you. It is one of the costlier tests in a workup, so ask what it covers and whether your scheme pays. At CION Cancer Clinics, our haematologist reviews abnormal blood reports with you, orders only the tests that answer your question and explains each result plainly.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What is a myeloid NGS panel, and why was it ordered?
- Which kinds of genes does the panel look at?
- How is NGS different from karyotype, FISH and PCR?
- What happens between the sample and the result?
- What decides the cost of a myeloid NGS panel in India?
- What do families often misunderstand about NGS results?
- What should you ask before agreeing to the test?
- Common questions about myeloid NGS panels
The short answer
What is a myeloid NGS panel, and why was it ordered?
A myeloid NGS panel reads dozens of genes in your blood or marrow cells in one test. It looks for the gene changes that drive myeloid blood cancers such as acute myeloid leukaemia (AML), myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN). NGS stands for next-generation sequencing, the method used to read the genes.
Why one panel instead of single tests
Older testing checked one gene at a time. Each test needed its own sample time and its own fee, and a change nobody thought to look for was missed. A panel checks the important genes together, so the full picture usually arrives in one report.
What the result is used for
The gene changes found help confirm the exact diagnosis, place the disease in a risk group and show whether a targeted medicine may suit you. In some cases they also help decide whether a stem cell transplant should be discussed early.
Who may not need one
Not everyone with an abnormal blood count needs a panel. If the cause is clearly not a myeloid blood cancer, such as low iron or an infection, the test adds cost without changing the plan. Your haematologist decides based on the marrow report and flow cytometry first.
What it cannot tell you
A panel describes the disease, not your future. It does not measure how fit you are for treatment, and it gives no timeline. Two people with the same gene change can do very differently, so read the report with your haematologist rather than searching each gene name online.
What gets tested
Which kinds of genes does the panel look at?
Panels differ between laboratories. Most group the genes by what a change in them tends to decide.
Genes that point to a treatment
Some changes have a matching targeted medicine. Finding them can add a tablet or an infusion to the plan.
Examples
- FLT3
- IDH1 and IDH2
Genes that shape the risk group
These change how the disease is expected to behave with standard treatment, and so what follows the first phase.
Examples
- NPM1 and CEBPA
- TP53, RUNX1 and ASXL1
Genes that confirm the diagnosis
In MDS and MPN, a gene change can show that a low or high count comes from a marrow disease and not from another cause.
Examples
- JAK2, CALR and MPL
- SF3B1
Changes of uncertain meaning
The report may list a variant of uncertain significance. It means the change was found but nobody yet knows whether it matters. It is not a new diagnosis.
Side by side
How is NGS different from karyotype, FISH and PCR?
Karyotype, FISH and PCR
Myeloid NGS panel
Karyotype and FISH see large chromosome changes
Reads small changes inside individual genes
PCR checks one known change at a time
Checks many genes in one run
Some results can come back within days
Usually takes longer, as samples are run in batches
Still needed alongside NGS in most cases
Does not replace chromosome tests
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
From sample to report
What happens between the sample and the result?
The sample
Usually taken during the bone marrow test, sometimes from blood when the count of abnormal cells in blood is high. No separate procedure is normally needed.
Sent to a specialist laboratory
Few laboratories run myeloid panels, so the sample often travels to another city. It must reach them in good condition, which is why timing and packaging matter.
Sequencing and analysis
The genes are read and the changes compared against large reference databases. A laboratory specialist then writes up which ones matter.
Explained in clinic
Your haematologist reads the report alongside the marrow, flow and chromosome results and tells you what, if anything, changes in the plan.
Indicative cost, 2026
What decides the cost of a myeloid NGS panel in India?
A myeloid NGS panel is one of the more expensive tests in a blood cancer workup. The price varies widely between laboratories, so ask for a written quote for your own panel before the sample is sent.
What moves the price up or down
The number of genes on the panel matters most. A small focused panel costs less than a large one. Whether the laboratory also reports gene fusions, how quickly it reports and whether courier charges are included all change the final bill. A cheaper panel that misses a gene your haematologist needs may mean a second test later. Ask whether the quote covers the whole panel or only part of it.
Schemes and insurance
Coverage for genetic tests is uneven. Aarogyasri, PM-JAY, CGHS, ECHS and EHS may cover it when it is part of an approved treatment package, and many cashless insurance policies pay for it as part of a hospital stay. Scheme rules change, so check the current rules with the scheme desk or your insurer before the test.
This page gives no rupee figure because prices differ so much. The helpline can help you get an estimate against your own cover.Commonly believed
What do families often misunderstand about NGS results?
"A gene change means our children will get it too."
Almost all changes found on a myeloid panel arose in the blood cells during life and are not inherited. If the report suggests an inherited change, your team will say so and suggest a separate test.
"No mutation found means no cancer."
A panel only reads the genes on its list. Some myeloid cancers carry changes it does not cover. The diagnosis still rests on the marrow report and flow cytometry, not the panel alone.
"Treatment should wait until every gene result is back."
When acute leukaemia is causing low counts or infections, waiting can be unsafe. Your team may start treatment and adjust once the panel returns. That is a judgement for them, made case by case.
"More genes on the panel is always better."
A larger panel finds more variants of uncertain meaning that change nothing. The useful panel covers the genes your diagnosis actually needs.
Before the sample goes
What should you ask before agreeing to the test?
- Which laboratory will run it, and is it accredited
- How many genes the panel covers, and which ones matter for you
- How long the report usually takes to come back
- Whether treatment will start before the result arrives
- What the full cost is, including courier charges
- Whether your scheme or insurer will cover it
Questions we are asked
Common questions about myeloid NGS panels
Can the test be done on blood instead of bone marrow?
Sometimes. If many abnormal cells are circulating in the blood, a blood sample can give a reliable result. When the count of abnormal cells in blood is low, marrow is usually needed. Your haematologist will choose the sample that gives the most useful answer for your situation.
How long does a myeloid NGS report take?
It usually takes longer than the marrow and flow reports, because samples travel to a specialist laboratory and are often run in batches. Ask the laboratory for their usual reporting time when the sample is sent. Urgent genes, such as FLT3, may be checked by a quicker separate test.
What is a VAF on the report?
VAF stands for variant allele frequency. It roughly shows what share of the gene copies in the sample carry that change. It helps the laboratory judge whether a change is in the cancer cells or inherited. It is not a score of how serious the disease is.
Does CION run the panel in-house?
No. CION's haematology team decides whether a panel is needed, arranges the sample with an accredited laboratory and explains the report to you. The case is discussed at a tumour board, so the result is read with every other test before the plan is confirmed.
Will the test need to be repeated later?
Sometimes. If the disease comes back or changes behaviour, a new panel can show whether fresh gene changes have appeared, and whether another targeted medicine may help. It is not usually repeated routinely while treatment is going well.
My report lists a change of uncertain significance. Should I worry?
Usually not on its own. It means the change was found but there is not yet enough evidence to say whether it matters. Treatment decisions are not normally based on it. Ask your haematologist whether it needs any follow-up, such as testing a non-cancer sample.
Is NGS needed for chronic myeloid leukaemia?
Not usually at diagnosis. Chronic myeloid leukaemia is confirmed by finding the BCR-ABL1 change, which uses PCR or FISH. A panel or a focused gene test may be used later if the disease stops responding to treatment, to look for resistance changes.
Can we get an older sample tested instead of a new marrow?
It depends on how the sample was stored and how long ago it was taken. Some laboratories can use stored material, others cannot. Ask the laboratory that holds the sample, and let your haematologist decide whether an older result still reflects the disease today.
What moves the figure
What affects the cost
Four things change the total more than anything else.
The technique used
A shaped or image-guided delivery costs more than a conventional one, and is chosen on clinical grounds rather than preference.
How many sessions
The total is driven by the number of sittings or cycles, not by a single per-visit figure.
Supporting tests
Scans, blood work and pathology done alongside treatment are billed separately.
Your cover
Aarogyasri, CGHS, ECHS, EHS or cashless insurance usually change the out-of-pocket figure substantially.
Paying for it
Insurance, schemes and payment
What you actually pay usually differs a great deal from the sticker figure.
AarogyasriEmpanelled. Bring the card and a referral where you have one.
CGHS / ECHS / EHSAccepted at CION centres for eligible treatment.
Cashless insuranceMost major insurers are empanelled. Pre-authorisation is handled by our desk.
Self-payItemised estimate given before treatment starts. No EMI scheme exists.
Accreditation and empanelment
- NABH
- NABL
- ISO 9001:2015
- ArogyaSri empanelled
- CGHS accepted
- ECHS accepted
- EHS accepted
- Major cashless insurers
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. A haematology consultation can be booked at any of these centres through one helpline, and your team will tell you where each test or treatment takes place.
Warangal
Vizag
Sources
- National Cancer Institute — Biomarker Testing for Cancer Treatment
- American Cancer Society — Acute Myeloid Leukemia (AML)
- Leukemia & Lymphoma Society — Acute Myeloid Leukemia
- Cancer.Net — Leukemia - Acute Myeloid - AML
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Karyotype and FISH in Leukaemia: Why They Change TreatmentThe chromosome tests that run alongside the panelRisk Stratification: Favourable, Intermediate, AdverseHow gene results turn into a risk groupCost of the Full Haematology Diagnostic WorkupWhere the panel sits in the total billHow Long Haematology Results Take, Test by TestWhen to expect each report
Talk to us
Unsure whether you need a gene panel?
Share your marrow report or call the helpline. The haematology team will explain which tests matter for your diagnosis and help you check your cover.